Monthly Archives: February 2012

Local physician involved in clinical trials of Erivedge™ (Vismodegib), the First Medicine for Adults with Advanced Basal Cell Carcinoma

Houston, TX - February 3, 2012 - Genentech announced that Erivedge ™ (vismodegib) capsule was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with basal cell carcinoma (BCC, a type of skin cancer.) Erivedge™ was approved on January 30, 2012. Dr. Leonard H. Goldberg, a Houston Dermatological surgeon, has …

Read More

Important New Developments in actinic keratoses and basal cell carcinoma!

New treatments have been approved for for both actinic keratoses and basal cell carcinoma.  From Skin and Allergy News: Actinic Keratoses "The Food and Drug Administration approved two strengths of ingenol mebutate gel for the treatment of actinic keratoses Jan. 23. The 0.015% formulation of ingenol mebutate gel (Picato) was approved for the treatment of …

Read More
Back to Top